Altamira Therapeutics Ltd. Contributions To Plan By Employer Net Defined Benefit Liability Asset
Altamira Therapeutics Ltd. (CYTOF) reported Contributions To Plan By Employer Net Defined Benefit Liability Asset of $147.42 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset · last filed 2025-04-30
CHF
| Period end | Contributions To Plan By Employer Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2023-12-31 | 130.88K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 154.12K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 101.07K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 76.03K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 107.62K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 146.25K CHF 20-F · filed 2020-04-16 |
USD
| Period end | Contributions To Plan By Employer Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2024-12-31 | $147.42K 20-F · filed 2025-04-30 |
| 2023-12-31 | $145.66K 20-F · filed 2025-04-30 |